Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

WT1

  • You have access
    Dendritic Cell-based Immunotherapy Pulsed With Wilms Tumor 1 Peptide and Mucin 1 as an Adjuvant Therapy for Pancreatic Ductal Adenocarcinoma After Curative Resection: A Phase I/IIa Clinical Trial
    KAZUHIRO NAGAI, TOMOHIKO ADACHI, HIROSHI HARADA, SUSUMU EGUCHI, HARUO SUGIYAMA and YASUSHI MIYAZAKI
    Anticancer Research October 2020, 40 (10) 5765-5776; DOI: https://doi.org/10.21873/anticanres.14593
  • You have access
    WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study
    RYU YANAGISAWA, TOMONOBU KOIZUMI, TERUTSUGU KOYA, KENJI SANO, SHIGEO KOIDO, KAZUHIRO NAGAI, MASANORI KOBAYASHI, MASATO OKAMOTO, HARUO SUGIYAMA and SHIGETAKA SHIMODAIRA
    Anticancer Research April 2018, 38 (4) 2217-2225;
  • You have access
    Immunohistochemical Analysis of WT1 Antigen Expression in Various Solid Cancer Cells
    KEIKO NAITOH, TAKASHI KAMIGAKI, ERIKO MATSUDA, HIROSHI IBE, SACHIKO OKADA, ERI OGUMA, YOSHIHIRO KINOSHITA, RISHU TAKIMOTO, KAORI MAKITA, SHUN OGASAWARA and SHIGENORI GOTO
    Anticancer Research July 2016, 36 (7) 3715-3724;
  • You have access
    Prognostic Markers for Patient Outcome Following Vaccination with Multiple MHC Class I/II-restricted WT1 Peptide-pulsed Dendritic Cells Plus Chemotherapy for Pancreatic Cancer
    KAZUKI TAKAKURA, SHIGEO KOIDO, SHIN KAN, KOSAKU YOSHIDA, MASAKO MORI, YUTA HIRANO, ZENSHO ITO, HIROKO KOBAYASHI, SHINICHIRO TAKAMI, YOSHIHIRO MATSUMOTO, MIKIO KAJIHARA, TAKEYUKI MISAWA, MASATO OKAMOTO, HARUO SUGIYAMA, SADAMU HOMMA, TOSHIFUMI OHKUSA and HISAO TAJIRI
    Anticancer Research January 2015, 35 (1) 555-562;
  • You have access
    Immunogenic Modulation of Cholangiocarcinoma Cells by Chemoimmunotherapy
    SHIGEO KOIDO, SHIN KAN, KOSAKU YOSHIDA, SHINJI YOSHIZAKI, KAZUKI TAKAKURA, YOSHIHISA NAMIKI, SHINTARO TSUKINAGA, SHUNICHI ODAHARA, MIKIO KAJIHARA, MASATO OKAMOTO, MASAKI ITO, SEI-ICHI YUSA, JIANLIN GONG, HARUO SUGIYAMA, TOSHIFUMI OHKUSA, SADAMU HOMMA and HISAO TAJIRI
    Anticancer Research November 2014, 34 (11) 6353-6361;
  • You have access
    High Levels of Wilms' Tumor 1 (WT1) Expression Were Associated with Aggressive Clinical Features in Ovarian Cancer
    ZHIYANG LIU, KEIKO YAMANOUCHI, TSUYOSHI OHTAO, SOHEI MATSUMURA, MANABU SEINO, VIJI SHRIDHAR, TOSHIFUMI TAKAHASHI, KAZUHIRO TAKAHASHI and HIROHISA KURACHI
    Anticancer Research May 2014, 34 (5) 2331-2340;
  • You have access
    Correlation of Wilms' Tumor 1 Isoforms with HER2 and ER-α and its Oncogenic Role in Breast Cancer
    TAPANAWAN NASOMYON, SRILA SAMPHAO, SURASAK SANGKHATHAT, SOMRIT MAHATTANOBON and POTCHANAPOND GRAIDIST
    Anticancer Research March 2014, 34 (3) 1333-1342;
  • You have access
    Wilms' Tumor 1 Is Involved in Tumorigenicity of Glioblastoma by Regulating Cell Proliferation and Apoptosis
    NORIYUKI KIJIMA, NAOKI HOSEN, NAOKI KAGAWA, NAOYA HASHIMOTO, MANABU KINOSHITA, YUSUKE OJI, HARUO SUGIYAMA and TOSHIKI YOSHIMINE
    Anticancer Research January 2014, 34 (1) 61-67;
  • You have access
    Wilms' Tumor Gene 1 (WT1) – loaded Dendritic Cell Immunotherapy in Patients with Uterine Tumors: A Phase I/II Clinical Trial
    AN COOSEMANS, ANKE VANDERSTRAETEN, SANDRA TUYAERTS, TINA VERSCHUERE, PHILIPPE MOERMAN, ZWI N. BERNEMAN, IGNACE VERGOTE, FRÉDÉRIC AMANT and STEFAAN W. VAN GOOL
    Anticancer Research December 2013, 33 (12) 5495-5500;
  • You have access
    Immunological Response after WT1 mRNA-loaded Dendritic Cell Immunotherapy in Ovarian Carcinoma and Carcinosarcoma
    AN COOSEMANS, ANKE VANDERSTRAETEN, SANDRA TUYAERTS, TINA VERSCHUERE, PHILIPPE MOERMAN, ZWI BERNEMAN, IGNACE VERGOTE, FRÉDÉRIC AMANT and STEFAAN W. VAN GOOL
    Anticancer Research September 2013, 33 (9) 3855-3859;
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire